Skip to main content
Sona Nanotech Inc. logo

Sona Nanotech Inc. — Investor Relations & Filings

Ticker · SONA ISIN · CA83541C1059 CSE Professional, scientific and technical activities
Filings indexed 424 across all filing types
Latest filing 2023-02-06 Regulatory Filings
Country CA Canada
Listing CSE SONA

About Sona Nanotech Inc.

https://www.sonanano.com/

Sona Nanotech Inc. is a life sciences company specializing in the development and commercialization of proprietary, uniquely biocompatible gold nanorod (GNR) technology. The primary therapeutic focus is Targeted Hyperthermia Therapy (THT), a photothermal cancer treatment utilizing GNRs to deliver precision heat directly to solid tumors. THT is designed to reduce tumor burden and stimulate immunogenic cell death while minimizing harm to healthy tissue. Sona is advancing THT through clinical trials for solid cancers, including melanoma. Furthermore, the company manufactures and supplies its patented, CTAB-free gold nanoparticles (nanorods and nanospheres) for integration into advanced materials science and medical diagnostic applications, such as lateral flow assays.

Recent filings

Filing Released Lang Actions
Material change report - English.pdf
Regulatory Filings
2023-02-06 English
News release - English.pdf
Regulatory Filings
2023-01-26 English
News release - English.pdf
Regulatory Filings
2022-11-08 English
News release - English.pdf
Capital/Financing Update Classification · 90% confidence The document is a press release announcing a commercial agreement between Sona Nanotech Inc. and Siva Therapeutics. It discusses the terms of the agreement, the technology involved, and future plans but does not contain any financial statements, regulatory filings, or detailed financial data. It is not an earnings release, annual report, or any form of financial report. It is also not a regulatory filing or certification. The document is a corporate announcement about a commercial agreement, which fits best under the category of Capital/Financing Update (CAP) as it relates to a business arrangement with potential financial implications and future orders. The document length is 7555 characters, which is sufficient for a detailed announcement but does not contain financial data to classify as a report. Therefore, the most appropriate classification is CAP with high confidence.
2022-10-20 English
52-109FV2 - Certification of interim filings - CFO (E).pdf
Regulatory Filings Classification · 100% confidence The document is a certification form titled 'FORM 52-109FV2 CERTIFICATION OF INTERIM FILINGS' by the CFO of Sona Nanotech Inc. It certifies the review and fair presentation of interim financial statements and interim MD&A for the period ended July 31, 2022. The document explicitly states it is a certification of interim filings, not the filings themselves. It contains no actual financial data or detailed financial statements, only the officer's attestation. According to the CERTIFICATION RULE, such documents should be classified as Regulatory Filings (RNS) rather than as an Interim Report (IR). The document length is short (3042 characters), consistent with a certification letter rather than a full report.
2022-09-26 English
52-109FV2 - Certification of interim filings - CEO (E).pdf
Regulatory Filings Classification · 100% confidence The document is a Form 52-109FV2 Certification of Interim Filings by the CEO of Sona Nanotech Inc. It certifies the review and fair presentation of interim financial statements and MD&A for the period ended July 31, 2022. The text explicitly states it is a certification document, not the interim report itself. It also references that it is a Venture Issuer Basic Certificate, which is a regulatory attestation. The document length is short (3033 characters) and contains no actual financial data or analysis, only the certification statement. According to the Certification Rule, such officer certifications should be classified as Regulatory Filings (RNS), not as the interim report (IR) itself. Therefore, the correct classification is Regulatory Filings (RNS).
2022-09-26 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.